Home › Companies › GILEAD SCIENCES INC. › 2024-2025

GILEAD SCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and GILEAD SCIENCES INC.’s Form 8-K, filed May 8, 2025 (Item 5.07 on EDGAR). Page generated October 13, 2026.

  • 15Ballot items
  • 1,296Asset managers
  • 20,844Fund votes
  • May 7, 2025Meeting date

Results at a glance

Meeting of May 7, 2025: 15 items on GILEAD SCIENCES INC.’s Form 8-K, filed May 8, 2025: 2 approved · 4 not approved · 9 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GILEAD SCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by GILEAD SCIENCES INC.

These tallies are GILEAD SCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 8, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GILEAD SCIENCES INC. — official shareholder meeting results, meeting held May 7, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Jacqueline K. Barton, Ph.D. 1,000,339,79220,090,054949,540 --99,956,982 98%Not verified—
Elect Director: Jeffrey A. Bluestone, Ph.D. 1,004,363,60816,016,385999,393 --99,956,982 98%Not verified—
Elect Director: Sandra J. Horning, M.D. 990,521,48029,329,8511,528,055 --99,956,982 97%Not verified—
Elect Director: Kelly A. Kramer 990,682,35429,700,216996,816 --99,956,982 97%Not verified—
Elect Director: Ted W. Love, M.D. 1,004,482,72315,913,306983,357 --99,956,982 98%Not verified—
Elect Director: Harish Manwani 981,452,33438,691,4741,235,578 --99,956,982 96%Not verified—
Elect Director: Daniel P. O'Day 953,619,78263,040,7284,718,876 --99,956,982 94%Not verified—
Elect Director: Javier J. Rodriguez 1,004,096,17016,320,922962,294 --99,956,982 98%Not verified—
Elect Director: Anthony Welters 986,829,94532,992,7621,556,679 --99,956,982 97%Not verified—
The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal received the following votes: 1,041,388,46878,979,344968,556 ---- 93%Approved—
The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes: 929,612,73989,351,5012,415,146 --99,956,982 91%Approved—
The Company's stockholders did not approve a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs. The proposal received the following votes: 81,515,333935,564,3364,299,717 --99,956,982 8%Not approved—
The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy. The proposal received the following votes: 370,171,536649,612,2201,595,630 --99,956,982 36%Not approved—
The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process. The proposal received the following votes: 366,777,151620,731,09633,871,139 --99,956,982 37%Not approved—
The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors. The proposal received the following votes: 10,110,5551,007,018,0344,250,797 --99,956,982 1.0%Not approved—

Source: GILEAD SCIENCES INC., Form 8-K, filed with the SEC on May 8, 2025 — read the filing on EDGAR.

How asset managers voted at the GILEAD SCIENCES INC. 2024-2025 meeting

Each item below shows how the 1,296 asset managers that disclosed a GILEAD SCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Jacqueline K. Barton, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 10 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,000,339,792AGAINST: 20,090,054
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Jacqueline K. Barton, Ph.D.”): 1,000,339,792 for, 20,090,054 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,155,043 for, 88,439 against, 182,711 abstained, 5,305 unknown.

FOR
FOR: 505,155,043AGAINST: 88,439ABSTAIN: 182,711UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32512 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

2. Elect Director: Jeffrey A. Bluestone, Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 12 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,363,608AGAINST: 16,016,385
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Jeffrey A. Bluestone, Ph.D.”): 1,004,363,608 for, 16,016,385 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,182,012 for, 61,465 against, 182,714 abstained, 5,305 unknown.

FOR
FOR: 505,182,012AGAINST: 61,465ABSTAIN: 182,714UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

3. Elect Director: Sandra J. Horning, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 11 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 990,521,480AGAINST: 29,329,851
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Sandra J. Horning, M.D.”): 990,521,480 for, 29,329,851 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,106,147 for, 137,293 against, 182,752 abstained, 5,305 unknown.

FOR
FOR: 505,106,147AGAINST: 137,293ABSTAIN: 182,752UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32116 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

4. Elect Director: Kelly A. Kramer

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 10 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 990,682,354AGAINST: 29,700,216
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Kelly A. Kramer”): 990,682,354 for, 29,700,216 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,027,242 for, 216,235 against, 182,714 abstained, 5,305 unknown.

FOR
FOR: 505,027,242AGAINST: 216,235ABSTAIN: 182,714UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,492,19417,143 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

5. Elect Director: Ted W. Love, M.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 12 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,482,723AGAINST: 15,913,306
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Ted W. Love, M.D.”): 1,004,482,723 for, 15,913,306 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,146,308 for, 65,207 against, 214,677 abstained, 5,305 unknown.

FOR
FOR: 505,146,308AGAINST: 65,207ABSTAIN: 214,677UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

6. Elect Director: Harish Manwani

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 10 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 981,452,334AGAINST: 38,691,474
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Harish Manwani”): 981,452,334 for, 38,691,474 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 503,629,507 for, 1,613,954 against, 182,731 abstained, 5,305 unknown.

FOR
FOR: 503,629,507AGAINST: 1,613,954ABSTAIN: 182,731UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,31423 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

7. Elect Director: Daniel P. O'Day

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 11 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 953,619,782AGAINST: 63,040,728
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Daniel P. O'Day”): 953,619,782 for, 63,040,728 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 504,695,217 for, 547,995 against, 182,980 abstained, 5,305 unknown.

FOR
FOR: 504,695,217AGAINST: 547,995ABSTAIN: 182,980UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,29738 30For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,54092 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

8. Elect Director: Javier J. Rodriguez

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,096,170AGAINST: 16,320,922
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Javier J. Rodriguez”): 1,004,096,170 for, 16,320,922 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,156,762 for, 86,719 against, 182,712 abstained, 5,305 unknown.

FOR
FOR: 505,156,762AGAINST: 86,719ABSTAIN: 182,712UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

9. Elect Director: Anthony Welters

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 986,829,945AGAINST: 32,992,762
Details: description as filed, official tally, votes by 217 asset managers

Description as filed by funds: To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Anthony Welters”): 986,829,945 for, 32,992,762 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 217 asset managers below reported 505,067,648 for, 175,789 against, 182,754 abstained, 5,305 unknown.

FOR
FOR: 505,067,648AGAINST: 175,789ABSTAIN: 182,754UNKNOWN: 5,305
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,31720 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

10. The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 29 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 929,612,739AGAINST: 89,351,501
Details: description as filed, official tally, votes by 1,286 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 929,612,739 for, 89,351,501 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement.”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 203 asset managers voting on “To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy S” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,28452 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,400232 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,873,5831,027 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,431,134396,606 00Mixed
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon265,1531,231,721 00Mixed

Fund voting reports, all 203 managers: 501,587,698 for, 2,755,410 against, 182,801 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1,117 asset managers voting on “To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy S” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capital Group57,422,5610 00For
Capital Research Global Investors55,619,1830 00For
Fidelity48,453,8030 00For
BlackRock48,355,4513,667 00For
State Street38,446,765483,246 00For
Dodge & Cox31,503,1700 00For
GEODE CAPITAL MANAGEMENT, LLC28,289,2490 00For
Wellington26,505,4260 00For
T. Rowe Price13,631,8255,775 00For
Northern Trust11,380,49768,344 00For
Invesco8,631,9460 00For
Charles Schwab8,306,3180 00For
Vanguard8,193,4350 00For
MELLON INVESTMENTS Corp6,855,3020 00For
Legal & General Investment Management Ltd135,4216,192,510 00Against
UBS6,194,914128,752 00For
JPMorgan6,276,9620 00For
AllianceBernstein6,184,8210 00For
Nuveen5,275,1310 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC05,115,245 00Against
VAN ECK ASSOCIATES CORP4,740,0280 00For
Federated Hermes4,729,2630 00For
Renaissance4,613,0170 00For
Amundi04,575,807 00Against
Citadel4,460,1800 00For

Institutional-manager reports, all 1,117 managers: 578,236,365 for, 59,790,318 against, 997,284 abstained, 231,414 not voted, 5,320 unknown. Showing the 25 largest; see all in the interactive database.

11. The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%
FOR: 1,041,388,468AGAINST: 78,979,344
Details: description as filed, official tally, votes by 215 asset managers

Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal received the following vote”): 1,041,388,468 for, 78,979,344 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of GILEAD SCIENCES INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 215 asset managers below reported 502,693,512 for, 2,142,275 against, 182,690 abstained, 400 unknown.

FOR
FOR: 502,693,512AGAINST: 2,142,275ABSTAIN: 182,690UNKNOWN: 400
Largest asset managers voting on “To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fisc” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,492,16517,173 00For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,400232 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,873,5831,027 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,431,134396,606 00Mixed
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon265,1531,231,721 00Mixed

Showing the 25 largest of 215 asset managers. See all 215 in the interactive database.

12. The Company's stockholders did not approve a stockholder proposal requesting the CEO pay ratio factor be included in…

Official resultCOMPENSATIONReported outcome: Not approved

Combines 16 wordings of this item as funds reported it.

8% Not approved · of votes cast

8%AGAINST
FOR: 81,515,333AGAINST: 935,564,336
Details: description as filed, official tally, votes by 254 asset managers

Description as filed by funds: To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs. The proposal received the following votes:”): 81,515,333 for, 935,564,336 against — failed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's stockholders did not approve a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs.”
Support: 8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 254 asset managers below reported 2,016,997 for, 501,667,786 against, 1,238,349 abstained, 5,026 not voted, 400 unknown.

AGAINST
FOR: 2,016,997AGAINST: 501,667,786ABSTAIN: 1,238,349NOT VOTED: 5,026UNKNOWN: 400
Largest asset managers voting on “To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive c” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard17,174129,492,161 20Against
Capital Group0100,814,724 00Against
Fidelity069,142,656 00Against
BlackRock24,86646,202,026 00Against
Dodge & Cox026,242,492 00Against
State Street1,31814,393,314 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford05,874,610 00Against
VanEck ETF Trust04,730,589 00Against
TIAA04,654,296 00Against
Victory Capital04,640,970 00Against
Invesco04,009,270 00Against
Jackson National03,827,740 00Against
JPMorgan03,583,940 00Against
Federated Hermes03,085,355 00Against
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon01,496,874 00Against

Showing the 25 largest of 254 asset managers. See all 254 in the interactive database.

13. The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and…

Official resultHUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEReported outcome: Not approved

Combines 10 wordings of this item as funds reported it.

37% Not approved · of votes cast

FOR 37%AGAINST
FOR: 366,777,151AGAINST: 620,731,096
Details: description as filed, official tally, votes by 221 asset managers

Description as filed by funds: To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process. The proposal received the following votes:”): 366,777,151 for, 620,731,096 against — failed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process.”
Support: 37% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 221 asset managers below reported 53,381,069 for, 426,207,046 against, 25,905,919 abstained, 1,010 unknown.

AGAINST
FOR: 53,381,069AGAINST: 426,207,046ABSTAIN: 25,905,919UNKNOWN: 1,010
Largest asset managers voting on “To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligenc” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard310,073129,199,244 210Against
Capital Group0100,814,724 00Against
Fidelity839,53043,334,046 24,969,0800Mixed
BlackRock40,15346,186,739 00Against
Dodge & Cox026,242,492 00Against
State Street3,77714,390,855 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional300,5177,962,312 00Against
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price06,151,664 00Against
Hartford1,0275,873,583 00Against
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital04,640,970 00Against
Invesco1,1494,008,121 00Against
Jackson National396,6063,431,134 00Mixed
JPMorgan2783,583,662 00Against
Federated Hermes3,085,3550 00For
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares1,977,6450 00For
BNY Mellon1,231,721265,153 00Mixed

Showing the 25 largest of 221 asset managers. See all 221 in the interactive database.

14. The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI…

Official resultDIVERSITY, EQUITY, AND INCLUSIONReported outcome: Not approved

Combines 10 wordings of this item as funds reported it.

1.0% Not approved · of votes cast

AGAINST
FOR: 10,110,555AGAINST: 1,007,018,034
Details: description as filed, official tally, votes by 218 asset managers

Description as filed by funds: To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors. The proposal received the following votes:”): 10,110,555 for, 1,007,018,034 against — failed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors.”
Support: 1.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 218 asset managers below reported 804,422 for, 503,687,274 against, 934,800 abstained, 5,305 unknown.

AGAINST
FOR: 804,422AGAINST: 503,687,274ABSTAIN: 934,800UNKNOWN: 5,305
Largest asset managers voting on “To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contract” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6129,509,329 30Against
Capital Group0100,814,724 00Against
Fidelity069,142,656 00Against
BlackRock046,226,892 00Against
Dodge & Cox026,242,492 00Against
State Street014,394,632 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford05,874,610 00Against
VanEck ETF Trust04,730,589 00Against
TIAA04,654,296 00Against
Victory Capital04,640,970 00Against
Invesco04,009,270 00Against
Jackson National03,827,740 00Against
JPMorgan03,583,940 00Against
Federated Hermes03,085,355 00Against
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon01,496,874 00Against

Showing the 25 largest of 218 asset managers. See all 218 in the interactive database.

15. The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy. The…

Official resultCORPORATE GOVERNANCEReported outcome: Not approved

Combines 5 wordings of this item as funds reported it.

36% Not approved · of votes cast

FOR 36%AGAINST
FOR: 370,171,536AGAINST: 649,612,220
Details: description as filed, official tally, votes by 209 asset managers

Description as filed by funds: To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy. The proposal received the following votes:”): 370,171,536 for, 649,612,220 against — failed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy.”
Support: 36% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of GILEAD SCIENCES INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Require Independent Board Chair” (10 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 209 asset managers below reported 158,365,185 for, 345,652,500 against, 182,752 abstained.

FORAGAINST
FOR: 158,365,185AGAINST: 345,652,500ABSTAIN: 182,752
Largest asset managers voting on “To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the A” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard17,130,092112,379,245 10Mixed
Capital Group100,814,7240 00For
Fidelity761,29768,381,359 00Against
BlackRock40,15346,186,739 00Against
Dodge & Cox026,242,492 00Against
State Street2,81114,391,821 00Against
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA04,654,296 00Against
Victory Capital1,2874,639,683 00Against
Invesco04,009,270 00Against
Jackson National3,175,769651,971 00Mixed
JPMorgan03,583,940 00Against
Federated Hermes3,085,3550 00For
First Trust02,974,121 00Against
WisdomTree2,899,8910 00For
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon265,1531,231,721 00Mixed

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 8, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest GILEAD SCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,245,000,000 shares outstanding at the time of that meeting.

Fund voting reports: top GILEAD SCIENCES INC. shareholders by shares voted on “To vote on a stockholder proposal requesting a comprehensive human rights policy and human…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 10.40%
2Capital Group 8.10%
3Fidelity 5.55%
4BlackRock 3.71%
5Dodge & Cox 2.11%
6State Street 1.16%
7INVESTMENT CO OF AMERICA 0.90%
8Dimensional 0.66%
9Charles Schwab 0.63%
10Pacer Funds Trust 0.52%
Institutional-manager reports: top GILEAD SCIENCES INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our Named Executive Officers as presented…”, 2024-2025
#Asset manager % of shares outstanding
1Capital Group 4.61%
2Capital Research Global Investors 4.47%
3Fidelity 3.89%
4BlackRock 3.88%
5State Street 3.13%
6Dodge & Cox 2.53%
7GEODE CAPITAL MANAGEMENT, LLC 2.27%
8Wellington 2.13%
9T. Rowe Price 1.10%
10Northern Trust 0.92%

Reported GILEAD SCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

GILEAD SCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
The Vanguard Group 8.98% DEF14A
BlackRock, Inc. 8.17% 13G
State Street 4.78% 13F
FMR (Fidelity) 4.70% 13F
Capital World Investors 4.32% 13G
Wellington Management 2.20% 13F
Morgan Stanley 1.59% 13F
Norges Bank 1.39% 13F
BNY Mellon 1.28% 13F
T. Rowe Price 1.18% 13F

Percentages above are of 1,245,000,000 shares outstanding, as reported by GILEAD SCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GILEAD SCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.

At GILEAD SCIENCES INC.'s shareholder meeting held May 7, 2025, in the 2024-2025 proxy season, 1,296 asset managers reported how they voted on 15 ballot items in their SEC Form N-PX filings, covering 20,844 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our Named Executive Officers as presented… — GILEAD SCIENCES INC.'s filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: GILEAD SCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 8, 2025.

GILEAD SCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.